Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2010
DOI: 10.1016/j.atherosclerosis.2010.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 32 publications
1
24
0
Order By: Relevance
“…Finally, the WT background for RFH swine was only recently developed, and this study used the most aged animals available from this herd. None of the previous publications describing the use of RFH swine as models for atherosclerosis and restenosis have included a background‐matched WT control 24, 25, 26, 27…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Finally, the WT background for RFH swine was only recently developed, and this study used the most aged animals available from this herd. None of the previous publications describing the use of RFH swine as models for atherosclerosis and restenosis have included a background‐matched WT control 24, 25, 26, 27…”
Section: Discussionmentioning
confidence: 99%
“…RFH swine express elevated LDL levels as a result of a mutation in the gene encoding the LDL receptor (LDL‐R),24 as is commonly observed in humans with FH. Due to their ability to develop complex atherosclerotic lesions that closely mimic those found in humans, these animals have been used extensively in the study of atherosclerosis over the past 2 decades,25 as well as in the development and validation of therapeutic and diagnostic cardiovascular technologies 26, 27. However, the heart valves of RFH swine have not previously been evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…As the arteries of RFH swine exist within the physiological milieu of the disease process, their responses to interventions are remarkably different to those in conventional swine models of induced atherosclerosis. The efficacy of antiproliferative agents (Tellez et al 2010b) coated on stents to counteract the phenomena of restenosis is greater in RFH swine than in the conventional swine model (Buszman et al 2014;Buszman et al 2013;Milewski et al 2011;Granada et al 2009). Because RFH swine better model this effect, this supports our assertion that models need to replicate the complexity of pathophysiology in order to mimic the safety and biocompatibility as it would be in humans.…”
Section: Cardiovascular Systemmentioning
confidence: 99%
“…The RFH swine (Rapacz et al 1994;Hasler-Rapacz et al 1998;Prescott et al 1991), a model of atherosclerosis developed and miniaturized at the University of WisconsinMadison, produces plaques spontaneously as a function of age in a manner remarkably similar to the human disease in time course, location, and phenotypic complexity, making it a platform for the development of cardiovascular imaging and interventional devices Tellez et al 2010b). Mature RFH mini-swine (Thim 2010), like humans (Finn et al 2010;Hansson and Libby 2006), display a large stenotic atherosclerotic burden with thin fibrous cap, a large necrotic core, presence of inflammatory infiltrates led by macrophages and foam cells, and intraplaque hemorrhages accompanied by adventitial and intraplaque neovascularization.…”
Section: Cardiovascular Systemmentioning
confidence: 99%
“…The majority of published studies have used total loading doses of aspirin and clopidogrel of approximately 300 mg, followed by maintenance daily doses of 75 to 100 mg of aspirin and 75 mg of clopidogrel (Seifert et al, 2007;Chung et al, 2010;Posa et al, 2010;Tellez et al, 2010). We use similar dosing schedules to those in humans undergoing stent deployment and load with 150 mg of aspirin and 150 mg of clopidogrel on both the day before and the day of the procedure, and then give 75 mg of each agent on a daily basis until the time of sacrifice.…”
Section: Procedural Techniquementioning
confidence: 99%